How the UAE is using AI and advanced technologies to transform gastroenterology and liver care

Date:

UAE’s agile regulatory framework accelerates the adoption of advances in diagnosis and treatment.

Dubai: Artificial intelligence (AI) and emerging medical technologies are creating new opportunities to improve the diagnosis and treatment of digestive and liver diseases, as the UAE steps up its focus on healthcare innovation, research and patient care.

These developments were among the topics discussed at the Emirates Gastroenterology and Hepatology Society (EGHS) Conference 2026, which brought together medical experts from the UAE, GCC and around the world at Hilton Dubai Al Habtoor City from November 20 to 22.

The three-day event featured discussions on the latest advances in gastroenterology, hepatology, diagnostic methods and medical technologies, with an emphasis on improving clinical practice and patient outcomes.

UAE backs AI-driven healthcare

The UAE’s agile healthcare governance system enables new medical treatments and technologies to be tested and integrated into healthcare services while ensuring they meet regulatory requirements, according to Dr Yousif Mohammed Al Serkal, Director-General of Emirates Health Services.

Speaking to on the second day of the conference, Al Serkal highlighted the country’s growing role in the global healthcare innovation ecosystem, particularly in adopting AI-powered solutions.

“When it comes to the adaptation of all the new treatments and technologies, the UAE has an agile governance system where a lot of these technologies get piloted and become part of the innovation of these products,” Al Serkal said.

He explained that government institutions, regulatory authorities and ministries work together to ensure new treatments and technologies in gastroenterology comply with approved standards and remain accessible to the population.

The UAE has also been among the early adopters of AI and agentic AI, supported by regulations governing the introduction of these technologies.

“These are the framework for introducing any of the AI-related diagnosis, such as devices or softwares, and these are monitored by various healthcare-related institutions and authorities,” he said.

Breakthroughs in digestive and liver care

In a separate interview, Dr Abdulla Al Hassani, President of the EGHS, discussed emerging treatments for metabolic dysfunction-associated steatohepatitis (MASH), a form of fatty liver disease.

“ In the old days, we had limited treatment, but nowadays we have significant changes and new treatments available to treat patients with fatty liver who have fibrosis, especially those with fibrosis grades 2 and 3,” Al Hassani told Gulf News.

A new medication was also introduced at the conference on its opening day, while workshops examined recent developments in diagnosing and treating the condition.

“It’s a medication which was recently approved in the UAE. It’s called ‘Resmerom’ and this is one of the medications which targets thyroid receptors. Studies show a significant reversal of the fibrosis among those patients who have fibrosis grades 2 and 3,” he said.

He added: “There’s also another medication approved by the FDA besides this medication, which is called ‘Ozempic,’ and it’s the same medication that is used for obesity. Again, this also showed some significant changes in the prognosis of liver fibrosis.”

Beyond medication, AI-assisted instruments and robotic technologies are also advancing gastroenterology procedures.

“Some procedures are operated by robotic way and have significant developments in the instruments used to do or perform gastroscopy, colonoscopy, and complicated procedures among gastroenterologists,” Al Hassani said.

He said the society’s annual conference aims to keep specialists informed about rapidly evolving medical developments and encourage knowledge-sharing with international colleagues.

Research and education drive progress

Sheikha Dr Noura Al Qassimi, President of the Emirates Medical Association, said the UAE continues to prioritise investment in medical education, scientific research and innovation to strengthen its position as a leading destination for healthcare excellence.

She highlighted how gastroenterology and hepatology are rapidly evolving medical fields, with significant advances in prevention, early detection, diagnosis and treatment.

“ These developments offer new opportunities to improve patient outcomes and quality of life, while highlighting the importance of continuous learning and keeping pace with scientific progress,” Al Qassimi said.

She described the EGHS conference as an important platform for sharing expertise, examining the latest medical developments and strengthening professional collaboration.

The ultimate priority, however, is to translate scientific knowledge into improved clinical practices and better patient care.

Global expertise comes together in Dubai

The EGHS Conference 2026 brought together clinical specialists, academics and leaders of regional medical societies, providing opportunities for knowledge exchange and stronger collaboration across the healthcare sector.

Its scientific programme covered several specialised fields, including inflammatory bowel disease, hepatology, advanced therapeutic endoscopy and gastrointestinal motility disorders.

As new technologies and treatment approaches continue to emerge, discussions at the conference highlighted the importance of research, continuous professional development and responsible innovation in advancing digestive and liver care.

For the UAE, the wider priority is to ensure that progress in medical science translates into earlier and more accurate diagnoses, improved treatment and better outcomes for patients.

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Dubai students show how to recover 24K gold from old mobile phones

Around 100 projects by university students and graduates from...

Sheikh Zayed Festival 2026: Free bus services, routes, timings and parking details announced

Free public buses will run on fixed schedules, providing...

Dubai–Sharjah traffic: UAE plans eight new bridges in major Al Ittihad Road upgrade

Al Nahda intersection capacity to increase by 65% to...